EWING SARCOMA
Clinical trials for EWING SARCOMA explained in plain language.
Never miss a new study
Get alerted when new EWING SARCOMA trials appear
Sign up with your email to follow new studies for EWING SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare bone cancer: drug combo trial targets toughest cases
Disease control OngoingThis early-stage trial tests whether adding the targeted drug regorafenib to standard chemotherapy is safe for people with newly diagnosed, widespread Ewing sarcoma. The study enrolls about 23 patients aged 2 to 49 whose cancer has spread beyond the lungs. The main goal is to fin…
Matched conditions: EWING SARCOMA
Phase: PHASE1 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated May 01, 2026 15:58 UTC
-
Immune cells from tumors could offer new hope for kids with relapsed cancers
Disease control OngoingThis study tests whether immune cells taken from a patient's own tumor can be safely given back to fight cancer. It includes children, teenagers, and young adults with solid tumors that have come back or stopped responding to standard treatments. The goal is to check for side eff…
Matched conditions: EWING SARCOMA
Phase: PHASE1 • Sponsor: Iovance Biotherapeutics, Inc. • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
New hope for kids with rare cancers: targeted drug shows promise in trial
Disease control OngoingThis study tests a daily pill called cabozantinib in children and young adults (up to age 30) with rare cancers like sarcomas, Wilms tumor, and others that have come back or not responded to treatment. The drug works by blocking signals that help tumors grow and form blood vessel…
Matched conditions: EWING SARCOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 30, 2026 15:55 UTC
-
New hope for kids with tough cancers: experimental drug CLR 131 enters human testing
Disease control OngoingThis early-stage study tests an experimental drug, CLR 131, in 30 children, adolescents, and young adults whose solid tumors, lymphoma, or brain tumors have returned or not responded to standard treatments. The main goal is to find a safe dose and check for side effects. Research…
Matched conditions: EWING SARCOMA
Phase: PHASE1 • Sponsor: Cellectar Biosciences, Inc. • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC